Skip to main content
April 22, 2025
Volume XV, Number 112
Legal Analysis. Expertly Written. Quickly Found.
Login
Publish / Advertise
Publish
Advertise
Publishing Firms
NLR Newsletters
Contact Us
Terms of Use
Privacy Policy
Search
About
Contact Us
NLR Team
Publishing Firms
NLR Newsletters
NLR Thought Leadership Awards
2018
2019
2020
2021
2022
NLR Blog
Terms of Use
Privacy Policy
Search
Quick Links
Type of Law
Antitrust Law
Artificial Intelligence Law News
Bankruptcy & Restructuring
Biotech, Food & Drug
Business of Law
Construction & Real Estate
Cybersecurity Media & FCC
Election & Legislative
Environmental & Energy
Family, Estates & Trusts
Financial, Securities & Banking
Global
Health Care Law
Immigration
Insurance
Intellectual Property Law
Labor & Employment
Litigation
Public Services, Infrastructure, Transportation
Tax
White Collar Crime & Consumer Rights
Legal Educational Events
NLR Blog
Contact Us
Search
Newsletters
All NLR Newsletters
AI & the Law Newsletter
NLR Career Center for Employers
NLR Career Center for Job Seekers
Trending
Most Recent
Type of Law
Antitrust, Mergers & Acquisitions, Trade
Artificial Intelligence Law News
Bankruptcy & Restructuring
Biotech, Cannabis, Food & Drug
Business of Law, Legal Marketing
Construction & Real Estate
Crime, Civil & Consumer Rights
Cybersecurity, Privacy, Media, & FCC
Election & Legislative
Environmental & Energy
Family, Estates & Trusts
Financial, SEC, Corporate, Banking
Global Law Updates
Government Contracting, Public Svc
Health Care Law
Immigration
Insurance
Intellectual Property Law
Labor & Employment
Litigation
Tax Law
Legal Educational Events
NLR Blog
Search
Career Center
Press Releases
GlobeNewswire Press Releases
NLR Press Releases
ACCESS Newswire
CLE
CLE Memberships
CLE Calendar
Trending News
How Are Family Offices Building Smarter Wealth? Structural Alpha (11 Examples)
DOJ Rule Restricting Sensitive Data Transfers Takes Effect
The Trump Administration’s Diversity, Equity, and Inclusion (DEI) Executive Orders: A Brief Primer
Trump Administration Announces "Reciprocal" Tariffs
What Every Multinational Company Should Know About … The Global and Reciprocal Tariffs Announcement
Blockading the Ports: U.S. Imposes 10% Global Tariff; Higher Reciprocal Tariff Rates by Country
Fifth Circuit Court of Appeals Negates Ruling on Federal Contractor Minimum Wage
New Executive Order Rescinds the $17.75 Per Hour Federal Contractor Minimum Wage
Medicare Telehealth Gets Another Temporary Lifeline – Will Congress Make it Permanent?
BREAKING: District Court Restores Status Quo Ante At NLRB
Federal Circuit / U.S. Court of Spec. Jurisdiction
Published between:
Min
Max
Title
Apply
Published
Title
Organization
Feb
17
2022
Federal Circuit Sends iPhone Patent Dispute Back for Third Damages Trial
McDermott Will & Emery
Feb
17
2022
Bargained-Away Rights to File for IPR May Not Be Recovered
McDermott Will & Emery
Feb
17
2022
Federal Circuit Tosses Shaw: IPR Estoppel Applies to All Claims, Grounds That Reasonably Could Have Been Raised
McDermott Will & Emery
Feb
15
2022
Plaintiff’s Third-Party Patent Licensing Information Can Be Sealed from Public View
Finnegan
Feb
15
2022
Petitioner Estopped Due to Final Written Decisions in Parallel IPR Proceedings with Petitions Filed Simultaneously
Finnegan
Feb
14
2022
Strategically Filed Request for Rehearing Leads PTAB to Institute IPR
Finnegan
Feb
14
2022
Federal Circuit Decision Reverses District Court Decision on Settlement
Finnegan
Feb
11
2022
Panel Rejects Status Quo Arguments and Upholds Injunction
Finnegan
Feb
10
2022
This .SUCKS: Trademark Applications for Identical Characters Is a No-Go
McDermott Will & Emery
Feb
10
2022
Federal Circuit Clarifies Applicant Admitted Prior Art Is Not a Basis for Inter Partes Review
Finnegan
Feb
10
2022
IPR Petition Cannot Be Based on Applicant Admitted Prior Art
McDermott Will & Emery
Feb
9
2022
The Reports of Shaw’s Death Were Not Greatly Exaggerated: Federal Circuit Confirms IPR Estoppel Applies to All Potential Grounds at the Petition Stage
Finnegan
Feb
9
2022
Spotlight on Upcoming Oral Arguments – February 2022
Finnegan
Feb
3
2022
Federal Circuit Rules AAPA in Challenged Patent Does Not Qualify as Prior Art Under 35 U.S.C § 311(B) But Signals AAPA Can Play Role in §103 Analysis
K&L Gates LLP
Feb
3
2022
Establishing Indefiniteness Requires More Than Identifying “Unanswered Questions”
McDermott Will & Emery
Feb
2
2022
Qualcomm v. Apple – Pyrrhic Victory for Qualcomm?
Schwegman, Lundberg & Woessner, P.A.
Jan
31
2022
Strengthen Software Claims Against Alice Challenges through Coined Terms and Depicting Technical Advantages in Figures
Mintz
Jan
27
2022
Power Play: District Court Properly Transferred Bad Faith Anticipatory Suit
McDermott Will & Emery
Jan
26
2022
Federal Circuit Drills Down on Ordinary Skill Requirement in Vacating ITC Infringement Determination
Finnegan
Jan
26
2022
Skinny Labels May Not Be Dead: Delaware District Court Distinguishes GSK, Dismisses Induced Infringement Claim
Proskauer Rose LLP
Jan
25
2022
Federal Circuit Reverses District Court’s Narrow Claim Construction Ruling
Finnegan
Jan
21
2022
TTAB Twofer: Board Denies Modification of SPO, Rules GDPR Does Not Apply in TTAB Proceedings
Finnegan
Jan
21
2022
Written Description Requirement Challenges: Federal Circuit Decision Sheds Light on How Expert Testimony Can Help
Mintz
Jan
20
2022
Magazine Reload: Claim Construction Error Requires Reversal and Remand
McDermott Will & Emery
Jan
13
2022
Choose the Words of Your Design Patent Applications Carefully
Foley & Lardner LLP
Jan
10
2022
Novartis v. Accord – No Limits on Negative Limitations?
Schwegman, Lundberg & Woessner, P.A.
Jan
10
2022
Substance Over Form: The Importance of Substantive Grounds in Parallel District-Court Litigation and Prior Petition IPR Denials in Opensky Indus., LLLC v. VLSI Tech. Llc
K&L Gates LLP
Jan
6
2022
Federal Circuit Weighs in on Prejudice in Bid Protests
Bradley Arant Boult Cummings LLP
Jan
6
2022
Improper Claim Construction Requires Partial Remand of Obviousness Determination
McDermott Will & Emery
Jan
6
2022
Change the Look of the Room: Appeal Transferred to Federal Circuit
McDermott Will & Emery
Jan
3
2022
The Virtues of Claiming Precisely What the FDA Approved!
Finnegan
Dec
29
2021
Biogen v. Mylan – Therapeutic v. Clinical Efficacy – What is Required by the Written Description Requirement?
Schwegman, Lundberg & Woessner, P.A.
Dec
21
2021
A Whole Lot of “Cobbl[e]”-ty Gook After Wertheim
Finnegan
Dec
20
2021
Moderna’s Appeal of PTAB Decision Dismissed for Lack of Standing
Finnegan
Dec
17
2021
Fintiv Factors 2 and 4 Save Petitioner’s Request for Rehearing
Finnegan
Pagination
Previous page
‹‹
Page 16
Next page
››
Subscribe to Federal Circuit / U.S. Court of Spec. Jurisdiction
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.
Sign Up for any (or all) of our 25+ Newsletters
FB
twt
mast
link
home
Cookies & Privacy